Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Ammonia | HCID 222 | — |
| Reactant | Bromotrimethylsilane | HCID 76113 | — |
| Reactant | Ergosine | HCID 105137 | — |
| Reactant | Ergocryptine | HCID 134551 | — |
| Reactant | HCID 54502730 | HCID 54502730 | — |
| Solvent | Dimethyl Sulfoxide | HCID 679 | — |
| Product | Bromocriptine | HCID 31101 | — |
Reaction Steps
9.1 ml of trimethylbromosilane are added to 1000 ml of anhydrous dimethylsulfoxide and the solution is stirred at room temperature for 15 minutes, then 10 g of a base mixture of α-ergocryptine and ergosine are added, which contains 64.2% of α-ergocryptine base, 28.46% of ergosine base, 2.78% of α-ergocryptinine base and 1.96% of ergosinine base. After stirring for 20 minutes, the mixture is poured into 5 liters of ice-water and the pH is made alkaline up to a value of 8 to 9 by adding aqueous ammonia. The mixture is extracted 3 times with 500 ml of dichloromethane each, the organic phases are combined and washed 3 times with 200 ml of 10% sodium chloride solution each. The dichloromethane phase is dried over anhydrous sodium sulfate, filtered and evaporated under reduced pressure. The residue is purified on a Kieselgel column by using ethyl acetate as eluant to give the title compound in a yield of 6.3 g (0.00967 mole, 87%) (as calculated for the starting base mixture), m.p.: 218° C.; as well as 2.9 g (0.0046 mole, 89%) of 2-bromoergosine, m.p.: 183°-185° C.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US04816587 |
|---|
| Source dataset | uspto-grants-1989_03 |
|---|
| ORD ID | ord-0bae6df6e2484a4dace8bf8b814be546 |
|---|
| Source note | uspto-grants-1989_03 |
|---|